Forendo Pharma

Turku, Finland Founded: 2013 • Age: 13 yrs Acquired By Organon
Small molecule therapeutics for reproductive health are developed.
Request Access

About Forendo Pharma

Forendo Pharma is a company based in Turku (Finland) founded in 2013 was acquired by Organon in November 2021.. Forendo Pharma has raised $25.58 million across 5 funding rounds from investors including Finnvera, Business Finland and Karolinska Development. Forendo Pharma operates in a competitive market with competitors including Sprout Pharmaceuticals, Hope Medicine, Rejoni, ObsEva and Gameto, among others.

  • Headquarter Turku, Finland
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $25.58 M (USD)

    in 5 rounds

  • Latest Funding Round
    $5.62 M (USD), Series A

    Jul 17, 2019

  • Investors
    Finnvera

    & 10 more

  • Employee Count
    Employee Count
  • Acquired by
    Organon

    (Nov 11, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Forendo Pharma

Forendo Pharma has successfully raised a total of $25.58M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $5.62 million completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Series A — $5.6M
  • First Round
  • Investors Count 10
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2019 Amount Series A - Forendo Pharma Valuation Sunstone
Sep, 2018 Amount Series A - Forendo Pharma Valuation Vesalius Biocapital III
Mar, 2018 Amount Debt – Conventional - Forendo Pharma Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Forendo Pharma

Forendo Pharma has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Finnvera, Business Finland and Karolinska Development. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investments are made by Sunstone in early-stage European companies.
Founded Year Domain Location
Venture capital firm investing in multiple sectors
Founded Year Domain Location
Investments are made in innovative life science companies globally.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Forendo Pharma

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Forendo Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Forendo Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Forendo Pharma

Forendo Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sprout Pharmaceuticals, Hope Medicine, Rejoni, ObsEva and Gameto, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Drugs for hypoactive sexual desire disorder in women are developed.
domain founded_year HQ Location
Monoclonal antibodies are developed for treating multiple diseases.
domain founded_year HQ Location
Therapeutics for women's health conditions are developed using innovative hydrogels.
domain founded_year HQ Location
Therapeutics for women's reproductive health and pregnancy are developed.
domain founded_year HQ Location
Therapeutics for fertility and menopause treatments are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Forendo Pharma

Frequently Asked Questions about Forendo Pharma

When was Forendo Pharma founded?

Forendo Pharma was founded in 2013.

Where is Forendo Pharma located?

Forendo Pharma is headquartered in Turku, Finland. It is registered at Turku, Varsinais-suomi, Finland.

Is Forendo Pharma a funded company?

Forendo Pharma is a funded company, having raised a total of $25.58M across 5 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $3.69M, raised on Jun 25, 2013.

What does Forendo Pharma do?

Forendo Pharma was founded in 2013 in Turku, Finland, and operates in the biotechnology sector focused on reproductive health. Small molecule therapeutics are developed by the company to regulate sex hormone effects in a tissue-specific manner. The pipeline includes Fispemifene, a selective estrogen receptor modulator in phase II trials for male hypogonadism, and an HSD17B1 enzyme inhibitor under investigation for endometriosis treatment.

Who are the top competitors of Forendo Pharma?

Forendo Pharma's top competitors include Sprout Pharmaceuticals, Rejoni and Hope Medicine.

Who are Forendo Pharma's investors?

Forendo Pharma has 11 investors. Key investors include Finnvera, Business Finland, Karolinska Development, MSVentures, and Sunstone.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available